← Eichor
Condition: Progressive Low Grade Glioma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Progressive Low Grade Glioma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma
Phase 2 · 35 location(s) · Day One Biopharmaceuticals, Inc. · NCT04775485SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
Phase 1/Phase 2 · 1 location(s) · St. Jude Children's Research Hospital · NCT04923126A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults With Brain Tumours
Phase 1 · 6 location(s) · Ipsen · NCT07441707Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade Glioma
EARLY_Phase 1 · 1 location(s) · Daniel Morgenstern · NCT06381570Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma
NA · 1 location(s) · University of California, San Francisco · NCT07506239
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.